Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) requiring enantiomeric purity. Its structure allows for selective reactions in asymmetric synthesis, making it valuable in producing drugs with specific stereochemistry. Commonly employed in the preparation of central nervous system agents and cardiovascular medications. Also utilized in research for developing novel therapeutic compounds where the (S)-enantiomer provides desired biological activity.